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Introduction
Hyperresponsiveness to bronchoconstrictors is a major pathophysiological feature in asthma. It can be defined as an increase in the ease and degree of airway narrowing in response to various bronchoconstrictor stimuli [1, 2] . Tumor necrosis factor-alpha (TNF-α) is recognized as an important pro-inflammatory cytokine with a large spectrum of activities, including the ability to induce airway hyperresponsiveness [3] [4] [5] . Kinins are mediators, produced in blood and tissues during inflammation and act by stimulating distinct receptors, such as bradykinin B 1 and B 2 receptors [6] . Bradykinin, a prominent member of the kinin family, is a potent bronchoconstrictor in asthmatic patients but has no such effects in healthy subjects [7] . Increased levels of TNF-α and bradykinin in bronchoalveolar lavage fluids from symptomatic asthmatic patients have suggested a relationship between TNF-α and bradykinin in the pathogenesis of asthma [8, 9] . We have recently, using a murine in-vitro model of chronic airway inflammation, demonstrated that prolonged exposure to TNF-α markedly enhanced contractile responses to des-Arg 9 -bradykinin and bradykinin in tracheal smooth muscle. This increase was paralleled with elevated mRNA levels for the bradykinin B 1 and B 2 receptors. In addition, mitogen-activated protein kinase (MAPK) pathways c-Jun Nterminal kinase (JNK) and extracellular signal-regulated kinase 1 and 2 (ERK 1/2) pathways were shown to be involved in this process [5] . Activation of MAPK pathway is known to induce gene transcription via stimulation of "down-stream" transcriptional factors [10] [11] [12] . TNF-α induced up-regulation of bradykinin B 1 and B 2 receptors might also partly depend on de novo transcription and synthesis of bradykinin B 1 and B 2 receptors.
Glucocorticoids have a wide range of inhibitory effects on the inflammatory process and the related immune response [13] . They bind to a single class of glucocorticoid receptors and cause either increase or decrease of gene expressions [14] . Glucocorticoids have been demonstrated to inhibit TNF-α-and interleukin-1β-induced up-regulation of bradykinin B 1 and B 2 receptors in human airway fibroblast and smooth muscle cells [15, 16] . Glucocorticoids have also been shown to enhance the gene transcription for bradykinin B 2 receptors in cultured airway smooth muscle cells [17] . Thus, the mechanisms behind the glucocorticoid effect on bradykinin receptors are not clear. The present study was designed to ascertain the effects of dexamethasone, a glucocorticoid, on the TNF-α-induced up-regulation of bradykinin B 1 and B 2 receptors in murine tracheal smooth muscle and to define the transcriptional mechanisms involved.
Material and Methods

Tissue preparation
10 weeks old male BALB/c J mice (MB A/S, Ry, Denmark) were sacrificed by cervical dislocation. The whole trachea was rapidly removed and placed into Dulbecco's Modified Eagle's Medium (DMEM; 4500 mg/l D-glucose, 110 mg/l sodium pyruvate, 584 mg/l L-glutamine) supplemented with penicillin (100 U/ml) and streptomycin (100 µg/ml). The trachea was then dissected free of adhering tissue under a microscope and cut into three to four segments, each with three cartilages per rings, for subsequent organ culture.
Organ culture
After the dissection, the segments were placed individually into wells of a 96-well plate (Ultra-low attachment; Sigma, St Louis, MO, U.S.A.) with 300 µl serum free DMEM incubated at 37 °C in humidified 5% CO 2 in air with and without TNF-α (100 ng/ml), in the absence and presence of actinomycin D (5 µg/ml), a general transcriptional inhibitor, for 1 day or dexamethasone (0.01, 0.1 or 1 µM), a glucocorticoid, for 4 days.
Segments were transferred into new wells containing fresh media including TNF-α, actinomycin D or dexamethasone every day.
In-vitro pharmacology
The cultured segments were immersed in temperature-controlled ( [18, 19] . At the end of the experiment a concentration-effect curve for carbachol was assessed.
Data Analysis
All data were expressed as mean values ± S.E.M. 
mRNA study
The tracheal smooth muscle was isolated mechanically on an ice tray under a microscope and the total RNA was extracted. Briefly, after removal of tracheal epithelium and cartilages, the smooth muscle strip was rinsed with cold PBS and stored in the RNAlater TM (QIAGEN GmbH, Hilden, Germany) at -80 °C until use for extraction of total RNA. The tracheal smooth muscle strips were homogenized and the total RNA was extracted by using the RNeasy Mini kit following the supplier's instructions (QIAGEN GmbH, Hilden, Germany). The purity of total RNA was checked by a spectrophotometer and the wavelength absorption ratio (260/280 nm) was between 1.6 and 2.0 in all preparations.
Reverse transcription (RT) of total RNA to cDNA was carried out using Omniscript All PCR primers used in the present study were designed by using Prime Express 
Results
Effects of dexamethasone
Organ To exclude possible toxic effects of dexamethasone, carbachol concentration-response curves were performed in the segments cultured for 4 days with and without TNF-α (100 ng/ml) in the presence of dexamethasone. The maximal contractions and the pEC 50 -values were not affected by dexamethasone (Fig. 3A-B) . Thus, data derived from the dexamethasone experiments are presented as percent of the carbachol-induced maximal contraction.
Effects of actinomycin D
To 
Receptor mRNA Study
To investigate if the TNF-α induced up-regulation of the bradykinin receptors were related to an increased de novo transcription of the receptor mRNA, the total RNA was extracted from the tracheal smooth muscle strips cultured for 1 or 4 days, in the absence and presence of TNF-α (100 ng/ml). The relative amount of mRNA for the bradykinin B 1
and B 2 receptors was quantified with real-time PCR. Enhanced mRNA levels of the bradykinin B 1 and B 2 receptors were found at 1 day (Fig. 5A, P<0 .001) and 4 days (Fig.   5B , P<0.001) of organ culture. These levels were further increased by TNF-α (100 ng/ml) (P<0.05).
To further confirm the involvement of transcriptional mechanisms, the tracheae were cultured with and without TNF-α (100 ng/ml), for 1 day in the presence of actinomycin D (5 µg/ml) or for 4 days in presence of dexamethasone (1 µM). In both cases, a significant inhibition of mRNA expression for the bradykinin B 1 and B 2 receptors was obtained ( Fig. 6A-B, P<0 .001).
Discussion
Airway inflammation induces airway smooth muscle hyperresponsiveness to various contractile mediators [1, 2] . We have previously demonstrated that TNF-α up-regulates bradykinin B 1 and B 2 receptor-mediated contractions in murine airways, a phenomenon that are paralleled with an increased mRNA expression for these receptors. This effect was at least partly mediated via the JNK and ERK 1/2 MAPK pathways [5] . The present study reveals that dexamethasone suppresses TNF-α-induced up-regulation of the bradykinin receptors via a transcriptional mechanism (Fig. 7) .
In the airways only small amounts of bradykinin B 2 receptors and no bradykinin B 1 receptors are expressed during physiological conditions [20, 21] . In the present set up no response to des-Arg 9 -bradykinin and only a weak contractile response to bradykinin could be seen in fresh tracheal segments, even though some mRNA for the bradykinin B 1 receptor could be detected [5] . This suggests that the tracheal segments used were in a TNF-α activates the MAPK and IkB kinase pathways resulting in gene transcription via the transcriptional factors NF-kB and AP-1 [12, 23, 24] . Actinomycin D is a transcriptional inhibitor which binds to double-helical DNA and inhibits DNA-directed RNA synthesis [25] . Dexamethasone is an inhibitor for NF-kB and AP-1 activity [26] [27] [28] [29] [30] .
In the present study, actinomycin D and dexamethasone both inhibited the TNF-α up- receptors. The inhibitory effects of dexamethasone were the same on both bradykinin receptor subtypes at the mRNA level, but differed in magnitude at the functional level.
At the latter level dexamethasone attenuated des-Arg 9 -bradykinin-induced contractions by 50%, whereas bradykinin induced contractions returned to the control level. This suggests that more than one mechanism might be involved in the up-regulation of the bradykinin B 1 and B 2 receptors. Such an assumption is in line with our previous finding that the two bradykinin receptors only partly uses the same intracellular signal transduction pathways for mediation of the TNF-α induced contractile up-regulation.
JNK and ERK1/2 pathways are involved in bradykinin B 2 receptor activation, whereas the JNK pathway, but not the ERK ½ pathways are associated with bradykinin B 1 receptors activation [5] . Another possibility is that bradykinin B 1 and B 2 receptor coupling might be affected by the TNF-α and/or dexamethasone treatment [31, 32] .
Glucocorticoids reduce airway hyperreactivity in the asthmatic airways [36] [37] [38] [39] and diminish airway inflammation via inhibition of the transcription factors AP-1 and NF-kB activities [28, 29, [33] [34] [35] . Dexamethasone inhibits the inducible bradykinin receptor expression in cultured human airway fibroblasts and smooth muscle cells [15, 16] . In contrast, methylprednisolone, another glucocorticoid, enhances the mRNA expression for bradykinin B 2 receptors in cultured guinea-pig tracheal smooth muscle cells. This upregulation is apparent at 3 hours, but not 7 hours after the methylprednisolone application [17] . Thus, it might be that constitutive and induced bradykinin receptors react differently in response to glucocorticoids. The use of different glucocorticoids as well as the time points chosen for analyse might also have effect the outcome.
In summary: As previously demonstrated, long-term exposure to TNF-α enhances the murine airway smooth muscle response to des-Arg 9 -bradykinin and bradykinin, a phenomenon known to dependent on the activation of different intracellular MAPK pathways [5] . In the present study this up-regulation is inhibited by dexamethasone and 
Figure 2
Contractile effects of (A) des-Arg 9 -bradykinin and (B) bradykinin in segments cultured for 4 days with TNF-α 100 ng/ml in the absence and presence of different concentrations of dexamethasone (DEX). Each data point is represented as the mean of all segments ±
S.E.M (n=6-10).
Figure 3
Contractile effects of carbachol in segments cultured for 4 day in (A) absence and (B) presence of TNF-α 100 ng/ml with and without dexamethasone (DEX). Each data point is represented as the mean of all segments ± S.E.M (n=4-6).
Figure 4
Contractile effects of (A) des-Arg 9 -bradykinin, (B) bradykinin and (C) carbachol in segments cultured for 1 day in the absence and presence of TNF-α 100 ng/ml with and without actinomycin D 5 µg/ml (ACD). Each data point is represented as the mean of all segments ± S.E.M (n=6-8). Demonstration of the hypothesis and experimental design for the present study.
P-IkB = IkB phosphorylation; TNF-R=TNF-receptors; DEX=dexamethasone;
ACD=actinomycin D. Statistical analysis was performed with unpaired student t test. P < 0.05 were considered to be significant; 
